glyceryl-2-arachidonate and Sepsis

glyceryl-2-arachidonate has been researched along with Sepsis* in 1 studies

Other Studies

1 other study(ies) available for glyceryl-2-arachidonate and Sepsis

Article	Year
Increase in the circulating endocannabinoid 2-arachidonoylglycerol is associated with gabapentin use in septic ICU patients. Endocrine, 2017, Volume: 58, Issue:1 Topics: Aged; Aged, 80 and over; Amines; Analgesics; APACHE; Arachidonic Acids; Critical Care; Critical Illness; Cyclohexanecarboxylic Acids; Endocannabinoids; Female; Gabapentin; gamma-Aminobutyric Acid; Glycerides; Humans; Intensive Care Units; Male; Middle Aged; Sepsis	2017

Article

Year

Increase in the circulating endocannabinoid 2-arachidonoylglycerol is associated with gabapentin use in septic ICU patients.

Endocrine, 2017, Volume: 58, Issue:1

Topics: Aged; Aged, 80 and over; Amines; Analgesics; APACHE; Arachidonic Acids; Critical Care; Critical Illness; Cyclohexanecarboxylic Acids; Endocannabinoids; Female; Gabapentin; gamma-Aminobutyric Acid; Glycerides; Humans; Intensive Care Units; Male; Middle Aged; Sepsis

2017